Arovella Therapeutics LimitedASX: ALA

Cell and Gene Innovation Spotlight Presentation

· Issued by Arovella Therapeutics Limited via ASX

Filed with ASX ·

ASX: ALA Arovella Therapeutics Limited ACN 090 987 250 Corporate One, 84 Hotham Street, Preston, VIC 3072 Australia Telephone: + 61 3 9863 6472 investor@arovella.com | www.arovella.com ASX Release 6 October 2026 AROVELLA PRESENTS AT THE CELL AND GENE MEETING IN PHOENIX, ARIZONA Highlights:...

View Attachment

6ix hasn’t read this filing yet.

Arovella Therapeutics Limited on 6ix

In the deck

Earlier from Arovella Therapeutics

Later from Arovella Therapeutics

All Arovella Therapeutics news releases